FSA
TCRT icon

Franklin Street Advisors’s Alaunos Therapeutics TCRT Stock Holding History

Franklin Street Advisors’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-274
Closed -$109K – 222
2014
Q3 		$109K Sell
274
-184
-40% -$88.7K 0.02% 218
2014
Q2 		$277K Buy
458
+31
+7% +$17.3K 0.05% 197
2014
Q1 		$294K Buy
+427
New +$286K 0.06% 194

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Street Advisors's TCRT Position: Q4 2014 in Review

Franklin Street Advisors sold out of Alaunos Therapeutics (TCRT) in Q4 2014, closing a stake of 274 shares — an estimated $109K sold.

Franklin Street Advisors first reported a position in TCRT in Q1 2014 and held it in 3 quarters. The position peaked at $294K in Q1 2014. 85 funds tracked by Wall St. Rank hold TCRT as of Q4 2014.

  • Franklin Street Advisors reported no remaining Alaunos Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Franklin Street Advisors sold 274 Alaunos Therapeutics shares in Q4 2014, an estimated $109K.
  • Franklin Street Advisors first reported a position in Alaunos Therapeutics in Q1 2014 and held it in 3 quarters.
  • Franklin Street Advisors's Alaunos Therapeutics position peaked at $294K in Q1 2014.
  • 85 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2014.

Based on Franklin Street Advisors's 13F filing for Q4 2014, filed 9 Jan 2015.